Get to know our clinical trials
Clinical trial in premenopausal women with early breast cancer.
THE MAIN PURPOSE OF THIS STUDY IS TO ANALYZE THE EFFICACY (TO FIND OUT THE DEGREE OF EFFECTIVENESS OF A TREATMENT) OF GIREDESTRANT COMPARED TO TAMOXIFEN AS A FIRST LINE OF TREATMENT BEFORE SURGERY.
Technical Summary
- PREOPERATIVE WINDOW OF OPPORTUNITY STUDY WITH GIREDESTRANT OR TAMOXIFEN IN PREMENOPAUSAL WOMEN WITH EARLY STAGE BREAST CANCER RE[]/HER2[-] AND KI67 =10%.
- Code EudraCT: 023-503565-36-00
- Protocol number: MEDOPP459
- Promoter: Medica Scientia Innovation Research SL
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.
Do you want to participate in this trial?
Request an appointment for our specialists to assess whether you qualify for this clinical trial
Do you prefer to send us your reports?
If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.